Jpmorgan Chase & CO Hookipa Pharma Inc. Transaction History

Jpmorgan Chase & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Dec 26, 2024	BUY	$0.59 - $1.04 $8 - $14	14 New	14 $0
Q1 2024 Dec 26, 2024	BUY	$0.61 - $0.83 $8 - $11	14 New	14 $0
Q4 2023 Dec 26, 2024	BUY	$0.42 - $0.86 $5 - $12	14 New	14 $0
Q2 2022 Aug 11, 2022	SELL	$1.33 - $2.31 $11,972 - $20,794	-9,002 Reduced 99.84%	14 $0
Q1 2022 May 11, 2022	SELL	$1.26 - $2.52 $104,929 - $209,858	-83,277 Reduced 90.23%	9,016 $21,000
Q4 2021 Feb 10, 2022	BUY	$2.33 - $5.94 $45,202 - $115,236	19,400 Added 26.61%	92,293 $215,000
Q3 2021 Nov 12, 2021	BUY	$5.89 - $9.35 $429,339 - $681,549	72,893 New	72,893 $429,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.